Skip to content

Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials.

Meta-analysis · Cardiovasc Revasc Med · 2019. Source record refreshed; an explanation has not been reviewed.

Meta-analysisSource: PubMed · PMID 29908826

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials.

Velagapudi P, Turagam M, Kolte D et al.
Cardiovasc Revasc Med · 2019

PubMed ID
29908826
Record checked

Linked publication notices

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.